Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Decroo

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 18, 2024
Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict-PPH study)Kehinde S Okunade, Aloy O Ugwu, Muisi A Adenekan, et al.
Plos One|February 22, 2024
Correction: Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort studyAnita Mesic, Tom Decroo, Htay Thet Mar, et al.
Plos One|July 29, 2022
Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort studyAnita Mesic, Tom Decroo, Htay Thet Mar, et al.
The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.
Respiratory Medicine|February 15, 2020
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievementsAlberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, et al.
BMJ Open|July 25, 2024
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trialJihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 11, 2022
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter centuryJean Claude S Ngabonziza, Leen Rigouts, Gabriela Torrea, et al.
The Lancet. Infectious Diseases|July 1, 2026
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trialKlaus Reither, Fiona Vanobberghen, Anna Verjans, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 18, 2024
Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict-PPH study)Kehinde S Okunade, Aloy O Ugwu, Muisi A Adenekan, et al.
Plos One|February 22, 2024
Correction: Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort studyAnita Mesic, Tom Decroo, Htay Thet Mar, et al.
Plos One|July 29, 2022
Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort studyAnita Mesic, Tom Decroo, Htay Thet Mar, et al.
The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.
Respiratory Medicine|February 15, 2020
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievementsAlberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, et al.
BMJ Open|July 25, 2024
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trialJihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 11, 2022
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter centuryJean Claude S Ngabonziza, Leen Rigouts, Gabriela Torrea, et al.
The Lancet. Infectious Diseases|July 1, 2026
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trialKlaus Reither, Fiona Vanobberghen, Anna Verjans, et al.
Pageof 14